Raymond Tu, MD, discusses the considerations for implementing a new lower dose mammography system, including patient safety, market share, and cost.
[[{"type":"media","view_mode":"media_crop","fid":"11562","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_9305716539806","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"205","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]When United Medical Center in Washington, D.C., upgraded their film-screen mammography system, they had several factors to consider, including how to best meet the needs of their underserved patient population while keeping costs in mind.
The push to lower radiation dose was also a major factor, said Raymond Tu, chairman of the Radiology Department at UMC and president of the American College of Radiology's Washington, D.C., chapter. In this podcast, Tu discusses why UMC opted for Philips’ MicroDose Mammography system, which the company launched in North America last fall.
Here, Tu details:
• The unique needs of his patient population, and how that factored into the selection of a new technology,
• The desire to select a solution that would help the group’s market share in the area, and
• The constraining factors keeping the industry from doing more to implement lower dose technologies.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.